Immune ageing at single-cell resolution

DA Mogilenko, I Shchukina, MN Artyomov - Nature Reviews …, 2022 - nature.com
Ageing leads to profound alterations in the immune system and increases susceptibility to
some chronic, infectious and autoimmune diseases. In recent years, widespread application …

Role of Bruton's tyrosine kinase in B cells and malignancies

S Pal Singh, F Dammeijer, RW Hendriks - Molecular cancer, 2018 - Springer
Bruton's tyrosine kinase (BTK) is a non-receptor kinase that plays a crucial role in oncogenic
signaling that is critical for proliferation and survival of leukemic cells in many B cell …

[HTML][HTML] Comprehensive profiling of an aging immune system reveals clonal GZMK+ CD8+ T cells as conserved hallmark of inflammaging

DA Mogilenko, O Shpynov, PS Andhey, L Arthur… - Immunity, 2021 - cell.com
Systematic understanding of immune aging on a whole-body scale is currently lacking. We
characterized age-associated alterations in immune cells across multiple mouse organs …

Toll-like receptor signaling drives Btk-mediated autoimmune disease

J Rip, MJW De Bruijn, MK Appelman… - Frontiers in …, 2019 - frontiersin.org
Bruton's tyrosine kinase (Btk) is a signaling molecule involved in development and activation
of B cells through B-cell receptor (BCR) and Toll-like receptor (TLR) signaling. We have …

lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway

ZY Sun, YK Jian, HY Zhu, B Li - Pathology-Research and Practice, 2019 - Elsevier
Background: LncRNA PVT1 has been reported to be involved in a variety of biological
processes, including cell proliferation, cell differentiation and cancer progression. However …

B cell receptor signaling and associated pathways in the pathogenesis of chronic lymphocytic leukemia

VK Schmid, E Hobeika - Frontiers in Oncology, 2024 - frontiersin.org
B cell antigen receptor (BCR) signaling is a key driver of growth and survival in both normal
and malignant B cells. Several lines of evidence support an important pathogenic role of the …

Secondary resistant mutations to small molecule inhibitors in cancer cells

AB Hamid, RC Petreaca - Cancers, 2020 - mdpi.com
Secondary resistant mutations in cancer cells arise in response to certain small molecule
inhibitors. These mutations inevitably cause recurrence and often progression to a more …

[HTML][HTML] The Mucolipin TRPML2 channel enhances the sensitivity of multiple myeloma cell lines to Ibrutinib and/or Bortezomib treatment

G Santoni, C Amantini, F Maggi, O Marinelli, M Santoni… - Biomolecules, 2022 - mdpi.com
Multiple myeloma (MM) is a haematological B cell malignancy characterised by clonal
proliferation of plasma cells and their accumulation in the bone marrow. The aim of the …

Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia

MK McKenna, SK Noothi, SS Alhakeem… - Blood, The Journal …, 2018 - ashpublications.org
Abstract Prostate apoptosis response-4 (Par-4), a proapoptotic tumor suppressor protein, is
downregulated in many cancers including renal cell carcinoma, glioblastoma, endometrial …

Aberrantly expressed Bruton's tyrosine kinase preferentially drives metastatic and stem cell-like phenotypes in neuroblastoma cells

NW Pikatan, YL Liu, OA Bamodu, M Hsiao, WM Hsu… - Cellular Oncology, 2020 - Springer
Purpose Neuroblastoma, a common childhood tumor, remains one of the most elusive
diseases to treat. To date, high-risk neuroblastoma is associated with low survival rates. To …